AFL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aflac is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to act now. The stock looks fundamentally solid and supported by positive institutional, congressional, and Japan growth developments, but the current setup is mixed: technical momentum is soft, analyst sentiment is split, and the latest earnings showed a revenue/EPS miss versus expectations even though year-over-year growth was strong. My direct view: hold for now rather than buy aggressively at this price.
AFL is trading near its pivot at 113.641 after closing at 113.64, which signals a neutral short-term setup. RSI_6 at 45.71 is neutral, so there is no oversold buying signal. The MACD histogram is -0.277 and negatively expanding, which suggests weakening momentum. Moving averages are converging, indicating a consolidation phase rather than a clear uptrend. Support is around 110.77 and 109, while resistance is 116.51 and 118.28. Overall, the current trend is sideways to mildly bearish in the near term, not an ideal immediate entry for an impatient buyer.
["Japan business sales increased 25.5%, showing strong growth in a key market.", "Aflac completed its first third-party reinsurance deal in Japan, which could support future diversification and earnings flexibility.", "Hedge funds are buying aggressively, indicating institutional accumulation.", "Congress trading data shows 1 purchase and 0 sales in the past 90 days, a positive signal.", "Analyst price targets remain mostly in a reasonable range above or near the current price, with some firms still positive on the stock."]
["Latest reported quarter missed revenue and adjusted EPS expectations.", "Persistency and lapse-rate issues in Japan remain a concern.", "MACD momentum is negative and expanding.", "Several analysts are cautious to bearish, with Underperform and Underweight ratings in the recent flow.", "Price target cuts from multiple firms suggest slowing enthusiasm.", "The stock is not receiving a strong proprietary buy signal from AI Stock Picker or SwingMax."]
In 2026/Q1, Aflac reported revenue of $4.346 billion, up 27.9% year over year, net income of $1.019 billion, up 3413.79% year over year, and EPS of $1.98, up 3860% year over year. That year-over-year growth is very strong and suggests operating improvement, but the news summary also says revenue was $4.24 billion, below expectations, and adjusted EPS of $1.75 missed the $1.80 estimate. For the latest quarter season, Q1 2026, the company showed strong underlying growth but still had an earnings miss, so the financial picture is positive on trend but not clean on execution.
Recent analyst action is mixed to negative. Mizuho cut its target to $104 and kept Underperform, Barclays cut to $99 and kept Underweight, while Piper Sandler reduced its target to $125 but kept Overweight. Keefe Bruyette and UBS were more neutral, with targets around $113-$115 and Market Perform/Neutral views. The overall Wall Street pros and cons view is split: bulls like the underlying business and Japan distribution strength, while bears focus on earnings pressure, challenging margins, and limited upside. Net takeaway: sentiment has softened, with more caution than conviction.
